Astrin Biosciences Earns CAP Accreditation for World's First Deep Proteomics Blood Test for Breast Cancer Detection

CLIA certification and CAP accreditation strengthen Astrin's foundation following launch of Certitude™ Breast, the first non-imaging breast cancer detection blood test that is available in select U.S. markets ST. PAUL, Minn., April 23, 2026 /PRNewswire/ -- Astrin Biosciences has been...